National Cancer Institute and ACRIN launched first multicenter study to compare digital mammography
On Sept. 4. 2001, the National Cancer Institute (NCI) and the American College of Radiology Imaging Network launched…
-
-
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
President Bill Clinton signed into law the Semipostal Authorization Act
On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…
-
The Study of Tamoxifen and Raloxifene began recruiting volunteers
On May 25, 1999. the Study of Tamoxifen and Raloxifene, or STAR, one of the largest breast cancer…
-
Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer prevention
In 1999, Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
-
Breast Cancer Prevention Trial Results published
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer stamp was first issued
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
-
Biotechnology | Diagnostics | Disease | Medical Device | Oncology | Radiology | U.S. Congress | Women's Health
Mammography Quality Standards Reauthorization Act continued 1992 Act until 2002
In 1998, the Mammography Quality Standards Reauthorization Act (MQSA) was passed by the U.S. Congress and continued the…
-
Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, reduced the incidence of some breast cancer outcomes
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
-
Biotechnology | Diagnostics | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer Act (PL 105-41) was signed into law
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
-
National Cancer Advisory Board recommended women age 40 years and older receive screening mammograms every one to two years
On Apr. 16, 1997, the American Cancer Society (ACS) published its recommended mammography screening interval for women ages…
-
the Art behind the Breast Cancer Research Postage Stamp
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved anastrozole (Arimidex) as a treatment for breast cancer
Dec. 27, 1995, the U.S. Food and Drug Administration (FDA) approved anastrozole (Arimidex) as a treatment for breast…
-
Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
-
BRCA2 gene mapped to chromosome 13q12-13
In 1995, the BRCA2 gene was mapped to chromosomal 13q. Just fifteen months later, Wooster et al. reported…
-
Scientists cloned the tumor suppressor genes BRCA1 and BRCA2
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
-
Biotechnology | Cloning | Diagnostics | Disease | Genomics | Oncology | Therapeutics | Women's Health
BRCA1 breast cancer-associated gene was identified by positional cloning methods
On Oct. 7, 1994, a strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility to breast and…
-
The NIH Revitalization Act of 1993 was signed
On Jun. 10, 1993, the U.S. Congress signed the National Institutes of Health Revitalization Act, P.L. 103-43. The…
-
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
-
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
-
Diagnostics | FDA | NIH | Oncology | Radiology | U.S. Congress | Women's Health
The Mammography Quality Standards Act was passed by the US Congress
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress…
-
The CDC began developing a national strategic plan for early detection and control of breast and cervical cancers
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
-
Biotechnology | Cardiology | Diagnostics | Disease | NIH | Oncology | Radiology | Therapeutics | Women's Health
The Women’s Health Initiative was launched
In 1991, the Women’s Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), was…
-
Biotechnology | Diagnostics | Disease | Genomics | Non-Profit Research | Oncology | Therapeutics | Women's Health
Geneticist Mary-Claire King discovered BRCA1, the first gene for a hereditary form of breast cancer.
In 1990, Geneticist Mary-Claire King and her colleagues at the University of California, Berkeley (UC Berkeley) discovered BRCA1,…
-
Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells
In 1989, Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells….
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Women's Health
The human HER2 proto-oncogene was cloned
In 1986, the human HER2 proto-oncogene was cloned. HER2 is also called neu and erbB2. This finding established…
-
The Mallinckrodt of Radiology introduced the first mobile mammography unit in the St. Louis region
In 1986, the Mallinckrodt Institute of Radiology and the former Barnes Hospital introduced the first mobile mammography unit…
-
Lumpectomy plus radiation therapy is found equivalent to mastectomy for early breast cancer
In 1985, Lumpectomy plus radiation therapy was found equivalent to mastectomy for early breast cancer. Lumpectomy followed by…
-
Scientists discovered the HER2 gene
In 1985, the HER2 oncogene was discovered by Axel Ullrich, a young scientist at Genentech. The new oncogene…
